Myoclonus and its disorders

Neurologic Clinics

Volumn 19, Issue 3, 2001, Pages 723-734

  Blindauer, Karen ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALUMINUM; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BISMUTH; BROMOCRIPTINE; CARDIOVASCULAR AGENT; CHLORAMBUCIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; HYDROMORPHONE; LAMOTRIGINE; LEVODOPA; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NARCOTIC AGENT; NIFEDIPINE; PETHIDINE; PHENYTOIN; PHYSOSTIGMINE; PREDNIMUSTINE; PSEUDOEPHEDRINE; PSYCHOTROPIC AGENT; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; TETRABENAZINE; TOXIN; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; MYOCLONUS; NEUROCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREMOR;

EID: 0034851101     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70042-6     Document Type: Article

References (67)

1. Myoclonus associated with the use of gabapentin
2. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus
3. Myoclonus
4. Myoclonus: A practical guide to drug therapy
5. Axial myoclonus of propiospinal origin
6. Benzodiazepines
7. Observation anatomo-clinique d'un syndrome myoclonique post-anoxique
8. The incidence and prevalence of myoclonus in Olmstead County, Minnesota
9. Myoclonus
10. Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor and clonazepam
11. Pathological findings in a case of hypoxic myoclonus treated with 5-HTP and a decarboxylase inhibitor
12. Beneficial effects of serotonin precursors in postanoxic action myoclonus
13. Symptomatic and essential palatal tremor
14. Problems in the dyskinesias
15. Definition and classification of myoclonus
16. Carvedilol-induced myoclonus
17. The clinical spectrum of posthypoxic myoclonus
18. Palatal myoclonus associated with decrease in 5-HIAA in CSF and responding to clonazepam
19. Clinical, biochemical, and pharmacological observation in a patient with post-asphyxic myoclonus: Association with serotonin hyperactivity
20. Serotonergic mechanisms in myoclonus
21. 1-5 Hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent
22. Physiology of human posthypoxic myoclonus
23. Cortical reflex myoclonus
24. Reticular reflex myoclonus: A physiological type of human post-hypoxic myoclonus
25. Myoclonies extrapyramidales traitee par coagulation sterotaxique que de la voie dentato-thalmique et leur mecanisme physiopathologique
26. Postmortem studies on posthypoxic and postmethyl bromide intoxication: Case reports
27. Peri-rolandic and fronto-parietal components of scalp-recorded giant SEPs in cortical myoclonus, electroencephalog
28. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: Evidence of cholinergic dysfunction
29. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases
30. Drug-induced movement disorders
31. Animal model of posthypoxic myoclonus: II. Neurochemical, pathological, and pharmacologic characterization
32. CSF neurochemistry in the myoclonic subtype of Alzheimer's disease
33. Familial essential myoclonus
34. Myoclonus and dystonia: A family study
35. Neurostimulation of the ventral intermediate thalamic nucleus alleviates hereditary essential myoclonus
36. Palatal myoclonus
37. Homovanillic acid and 5-HIAA levels in CSF of patients with progressive myoclonus and epilepsy
38. Analyse pharmacologique d'un nouveau cas de myoclonies d'intention et d'action post-anoxique
39. Palatal myoclonus treated with 5-HTP and a decarboxylase inhibitor
40. Hereditary essential myoclonus
41. Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: An electroencephalographic study
42. Clinical neurophysiology of muscle jerks: Myoclonus, chorea and tics
43. The nosology and pathophysiology of myoclonus
44. Involvement of GABA A Receptor in myoclonus
45. Myoclonus secondary to albuterol (salbutamol) instillation
46. Cervical and facial myoclonus associated with dolichoectasia of the left vertebral artery
47. Classification, clinical features, and treatment of myoclonus
48. Treatment of severe action myoclonus
49. The spectrum of cortical myoclonus - From focal reflex jerks to spontaneous motor epilepsy
50. Serotonin and human myoclonus: Rational for the use of serotonin receptor agonists and antagonists
51. Essential myoclonus and myoclonic dystonia - A review
52. Treatment of palatal myoclonus with sumatriptan
53. Peripheral myoclonus due to spinal root lesion
54. Electrophysiological studies of myoclonus
55. Scalp topography of giant SEP and premyoclonus spike in cortical reflex myoclonus
56. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy
57. Electroencephalographic studies of myoclonus: Myoclonus-related cortical spikes in progressive myoclonic epilepsy
58. Rhythmic myoclonias including spinal myoclonus
59. A case of chronic toluene intoxication presenting stimulus-sensitive segmental spinal myoclonus
60. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: Clinical, electrophysiological, and biochemical observations
61. Pathophysiology of myoclonic disorders
62. Piracetam in the treatment of myoclonus: An overview
63. Biochemistry and therapeutics of posthypoxic myoclonus
64. Fluoxetine in the treatment of intention myoclonus
65. Therapy of intention myoclonus with 1-5 hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486
66. Panaencefalitis esclerosante subaguda del adulto con mioclonias segmentarias como sintoma inicial
67. An autopsy case of anoxic encephalopathy caused by transient upper airway obstruction